Search results for "Highlights"
AGA issues best practice advice on IBS and diet
Dietary advice is ideally prescribed to patients with irritable bowel syndrome (IBS) who have insight into their meal-related GI symptoms and are motivated to make changes, the American Gastroenterological Association (AGA) said.
https://gastroenterology.acponline.org/archives/2022/04/22/2.htm
22 Apr 2022
Noninvasive score for fibrotic NASH designed for, validated in primary care settings
Levels of aspartate aminotransferase, high-density lipoprotein cholesterol, and HbA1c can be used to predict which patients might need referral to a subspecialist for fibrotic nonalcoholic steatohepatitis (NASH).
https://gastroenterology.acponline.org/archives/2022/04/22/1.htm
22 Apr 2022
New guideline offers recommendations on managing antithrombotic drugs during GI bleeds, endoscopies
The American College of Gastroenterology and the Canadian Association of Gastroenterology offered suggestions for management of patients on warfarin, direct oral anticoagulants, and antiplatelet agents.
https://gastroenterology.acponline.org/archives/2022/03/25/1.htm
25 Mar 2022
Excess weight over time associated with increased CRC risk
A German study found that the weighted number of years lived with overweight and obesity was associated with a higher risk for colorectal cancer (CRC) than excess body mass index at a single point in time.
https://gastroenterology.acponline.org/archives/2022/03/25/3.htm
25 Mar 2022
U.S. sees increase in alcohol-associated liver disease mortality
Deaths from alcohol-associated liver disease increased among men and women, across all ages, and in all racial/ethnic populations in the U.S. from 2017 through 2020, leading researchers to call for a nationwide effort to reduce national alcohol consumption, improve screening, and optimize early treatment.
https://gastroenterology.acponline.org/archives/2022/03/25/2.htm
25 Mar 2022
U.S. sees decrease in HCC disease burden
Incidence of hepatocellular carcinoma (HCC) decreased sharply by 2.3% annually after 2011, while incidence-based mortality saw a 3.2% annual decrease after 2013, according to a study based on national data.
https://gastroenterology.acponline.org/archives/2022/02/25/2.htm
25 Feb 2022
Pandemic may have led to later presentation of colorectal, breast cancers
A single-center study in California found that more patients presented with stage I disease and fewer presented with stage IV disease in 2019 versus 2020, but the changes were statistically significant only for breast cancer.
https://gastroenterology.acponline.org/archives/2022/02/25/3.htm
25 Feb 2022
Infliximab or tofacitinib for IBD associated with lower response to COVID-19 vaccination
An industry-funded study in England looked at SARS-CoV-2 antibody concentrations after two vaccine doses among patients taking infliximab, tofacitinib, thiopurine, ustekinumab, or vedolizumab for inflammatory bowel disease (IBD), comparing them to healthy controls.
https://gastroenterology.acponline.org/archives/2022/02/25/1.htm
25 Feb 2022
Electronic alert about lactulose linked to lower readmissions in patients with cirrhosis
The alert, which encouraged clinicians to prescribe rifaximin for patients with cirrhosis and hepatic encephalopathy who were on lactulose, increased uptake of rifaximin in such patients.
https://gastroenterology.acponline.org/archives/2022/01/28/3.htm
28 Jan 2022
H. pylori eradication therapy may lead to better outcomes for functional dyspepsia
A systematic review and meta-analysis found that Helicobacter pylori eradication therapy was associated with higher cure rates and rates of symptom improvement in H. pylori-positive patients with functional dyspepsia.
https://gastroenterology.acponline.org/archives/2022/01/28/2.htm
28 Jan 2022